PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Leuprorelin acetate - Uterine fibroids
PAD Profile : Leuprorelin acetate - Uterine fibroids
Brand Names Include :
Prostap
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) agreed the following traffic light status for treating menorrhagia associated with fibroids:
GREEN traffic light status
- Tranexamic acid tablets
- Norethisterone
- Combined Hormonal Contraception
- Levonorgestrel intrauterine system (LNG-IUS) - Benilexa, levosert & Mirena
RED traffic light status
GnRH/LHRH analogues
- Triptorelin (Decapeptyl SR® 3.75mg)
- Leuprorelin (Prostap SR DCS®) 3.75mg
- Gosereline acetate (Zoladex® 3.6mg)
Associated BNF Codes
08. Malignant Disease and Immunosuppression
08.03.04. Hormone antagonists